Bristol-Myers Squibb BMY Correction Appears Complete
Companies / Company Chart Analysis Apr 28, 2010 - 03:00 PM GMTBy: Mike_Paulenoff
The price pattern and my near-term intermediate-term momentum work argue strongly that Bristol-Myers Squibb (NYSE: BMY) finished a corrective downleg at this morning's low of 24.07 off of its Mar 29 high at 27.07. As long as key support between 24.10 and 23.50 contains any acute (forthcoming) selling pressure, the larger base pattern from Sept 2008 remains intact and dominant.
If my near-term work proves accurate, then BMY will not see lower prices than this morning's low at 24.07. A climb that sustains above 24.45 will trigger initial confirmation signals that a new upleg is in progress.
Sign up for a free 15-day trial to Mike's ETF & Stock Trading Diary today.
By Mike Paulenoff
Mike Paulenoff is author of MPTrader.com (www.mptrader.com), a real-time diary of his technical analysis and trading alerts on ETFs covering metals, energy, equity indices, currencies, Treasuries, and specific industries and international regions.
© 2002-2010 MPTrader.com, an AdviceTrade publication. All rights reserved. Any publication, distribution, retransmission or reproduction of information or data contained on this Web site without written consent from MPTrader is prohibited. See our disclaimer.
Mike Paulenoff Archive |
© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.
